Case report of lichen planopilaris occurring in a pediatric patient receiving a tumor necrosis factor α inhibitor and a review of the literature

Pediatric Dermatology

Volumn 33, Issue 2, 2016, Pages e143-e146

  Jayasekera, Prativa S A ^a   Walsh, Maeve L ^b   Hurrell, Daniel ^c   Parslew, Richard A G ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ST HELENS AND KNOWSLEY TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CLOBETASOL PROPIONATE; ETANERCEPT; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; TOCILIZUMAB; TUMOR NECROSIS FACTOR;

ALOPECIA; ARACHNOID CYST; ARTHRITIS; ARTICLE; CASE REPORT; CHILD; DRUG EFFICACY; DRUG ERUPTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DRUSEN; EXTENDED OLIGOARTHRITIS; FEMALE; HISTOLOGY; HUMAN; LICHEN PLANOPILARIS; LICHEN PLANUS; MEDICAL HISTORY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCAR FORMATION; SCHOOL CHILD; SKIN BIOPSY; TOPICAL TREATMENT; TREATMENT DURATION; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED;

ADALIMUMAB; CHILD; FEMALE; HUMANS; LICHEN PLANUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957990185     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12768     Document Type: Article

References (21)

1. Asarch A, Gottlieb AB, Lee J, et al., Lichen planus-like eruptions: an emerging side effect of tumour necrosis factor-α anatagonists. J Am Acad Dermatol 2009; 61: 104-111.
2. Fiorentino DF,. The yin and yang of TNF-α inhibition. Arch Dermatol 2007; 143: 233-236.
3. De Vries HJ, van Marie J, Teunissen MB, et al., Lichen planus is associated with human herpes virus type 7 replication and infiltration of plasmacytoid dendritic cells. Br J Dermatol 2006; 154: 361-364.
4. Wenzel J, Scheler M, Proelss J, et al., Type I interferon-associated cytotoxic inflammation in lichen planus. J Cutan Pathol 2006; 33: 672-678.
5. Pinto JM, Marques MS, Correia TE,. Lichen planus and leucocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis. J Eur Acad Dermatol Venereol 2003; 17: 193-195.
6. Gallo E, Cabaleiro T, Román M, et al., The relationship between tumour necrosis factor (TNF)-α promoter and IL12B/IL-23R genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study. Br J Dermatol 2013; 169: 819-829.
7. Vegara G, Silvestre JF, Betlloch I, et al., Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002; 138: 1258-1259.
8. Devos SA, Van Den Bossche N, De Vos M, et al., Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology 2003; 206: 388-390.
9. Flendrie M, Vissers W, Creemers M, et al., Dermatological conditions during TNF-alpha blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 2005; 7: R666-R676.
10. Bovenschen HJ, Kop EN, Van De Kerkhof PC, et al., Etanercept-induced lichenoid reaction pattern in psoriasis. J Dermatolog Treat 2006; 17: 381-383.
11. Battistella M, Rivet J, Bachelez H, et al., Lichen planus associated with etanercept. Br J Dermatol 2008; 158: 188-190.
12. De Simone C, Caldarola G, D'Agostino M, et al., Lichenoid reaction induced by adalimumab. J Eur Acad Dermatol Venereol 2008; 22: 626-627.
13. Moss AC, Treister NS, Marsee DK, et al., Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab. Gastroenterology 2007; 132: 488, 829.
14. Lebas D, Staumont-Salle D, Solau-Gervais E, et al., Cutaneous manifestations during treatment with TNF- alpha blockers: 11 cases. Ann Dermatol Venereol 2007; 134: 337-342.
15. Garcovich S, Manco S, Zampetti A, et al., Onset of lichen planopilaris during treatment with etanercept. Br J Dermatol 2008; 158: 1161-1163.
16. Abbasi NR, Orlow SJ,. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis. Pediatr Dermatol 2009; 26: 118.
17. Musumeci ML, Lacarrubba F, Micali G,. Onset of lichen planus during treatment with etanercept. Am J Clin Dermatol 2010; 11: 55-56.
18. Garcovich S, Burlando M, Rongioletti F, et al., Cutaneous drug eruption with an interface dermatitis pattern due to anti-tumour necrosis factor-alpha agents: a relevant class-effect. Acta Derm Venereol 2010; 90: 311-312.
19. Fernández-Torres R, Paradela S, Valbuena L, et al., Infliximab-induced lichen planopilaris. Ann Pharmacother 2010; 44: 1501-1503.
20. Pontikaki I, Shahi E, Frasin LA, et al., Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis. Clin Rev Allergy Immunol 2012; 42: 131-134.
21. Worsnop F, Wee J, Natkunarajah J, et al., Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus. Clin Exp Dermatol 2012; 37: 879-881.